Published February 27, 2023 | Version v1

Encapsulation: A Strategy to Deliver Therapeutics and Bioactive Compounds?

  • 1. ROR icon Czech University of Life Sciences Prague
  • 2. Faculty of Agrobiology, Food and Natural Resources
  • 3. DRIFT-FOOD Research Centre
  • 4. Department of Immunology, Second Faculty of Medicine Charles University and Motol University Hospital

Description

There is a growing demand for efficient medical therapies without undesired side effects that limit their application. Targeted therapies such as deliveries of pharmacologically active compounds to a specific site of action in the human body are still a big challenge. Encapsulation is an effective tool for targeted deliveries of drugs and sensitive compounds. It has been exploited as a technique that can manage the required distribution, action and metabolism of encapsulated agents. Food supplements or functional foods containing encapsulated probiotics, vitamins, minerals or extracts are often part of therapies and currently also a consumption trend. For effective encapsulation, optimal manufacturing has to be ensured. Thus, there is a trend to develop new (or modify existing) encapsulation methods. The most-used encapsulation approaches are based on barriers made from (bio)polymers, liposomes, multiple emulsions, etc. In this paper, recent advances in the use of encapsulation in the fields of medicine, food supplements and functional foods are highlighted, with emphasis on its benefits within targeted and supportive treatments. We have focused on a comprehensive overview of encapsulation options in the field of medicine and functional preparations that complement them with their positive effects on human health.

Files

Encapsulation A Strategy to Deliver Therapeutics and Bioactive Compounds.pdf

Additional details

Funding

European Commission
DRIFT-FOOD - ADVANCED TECHNOLOGIES FOR HIGH QUALITY, SAFE AND SUSTAINABLE REGIONAL FOOD PRODUCTION 952594
Government of the Czech Republic
Specifická imunitní odpověď po očkování proti virovým patogenům u imunokompromitovaných pacientů NU22-05-00402

Dates

Accepted
2023-02-23